This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Minster Pharmaceuticals in Recommended Takeover by Proximagen Neuroscience

January 15, 2010

LONDON, January 15, 2010 — Covington & Burling LLP advised Minster Pharmaceuticals plc, the AIM-quoted drug development company specialising in compounds for the treatment of neurological and psychiatric conditions, in its recommended takeover by Proximagen Neuroscience plc. The terms of the all cash offer value Minster at £4.3 million.

The Covington team consisted of corporate partner Simon Amies, life sciences transactional partner Daniel Pavin, corporate associate James Baillieu and trainee Ian Redfearn. Partner Peter Laveran and associate Karen Brooks advised on US securities aspects of the transaction.

Share this article: